Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor Angiogenesis

1 May 2004

Abstract excerpt

Angiogenesis, the sprouting of new blood vessels from preexisting ones, is a phenomenon associated to several human pathologies, including different potentially blinding ocular disorders, rheumatoid arthritis, and cancer. Indeed, ongoing angiogenesis is a characteristic feature of the majority of aggressive solid tumors, and is also a pre-requisite for the progression towards the metastatic phenotype. One...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Adhesion Molecules Research
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15134574
DOI: 10.2174/1381612043384808

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor AngiogenesisPMID 15134574Read ↗

Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.Semantic proximity Read ↗

A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature <i>in vivo</i>Semantic proximity Read ↗

Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domainSemantic proximity Read ↗

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapySemantic proximity Read ↗

C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8.Semantic proximity Read ↗

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesisSemantic proximity Read ↗

Exploring the mechanism of fibronectin extra domain B in the tumor microenvironment and implications for targeted immunotherapy and diagnostics (Review)Semantic proximity Read ↗

Angiogenesis factors.Semantic proximity Read ↗

Consensus guidelines for the use and interpretation of angiogenesis assaysSemantic proximity Read ↗

RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life SciencesSemantic proximity Read ↗

A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignanciesSemantic proximity Read ↗

Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.